Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11 Clinical Trials in Houston, Texas

Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome